This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
If you hadn’t already noticed, the clinical research enterprise has well and truly entered the era of “bigdata,” artificial intelligence (AI), and machine learning. Edited by Gary Cramer The post Recognizing the Real People Behind the BigData and Artificial Intelligence in Clinical Research appeared first on ACRP.
With machine learning and bigdata analytics, companies can now predict market trends, enhance drug development, and create hyper-personalized campaigns. Bigdata analytics plays a crucial role in identifying prescribing patterns, understanding patient behaviors, and tailoring content strategies.
Case Study 1: Orphan Drug for Rare Genetic Disorder A mid-sized pharmaceutical company identified a branded orphan drug treating a rare genetic disorder. Case Study 2: Novel Formulation of Existing Drug A biotech firm discovered a branded drug with a novel formulation that significantly improved patient compliance.
It enables careful collation and organisation of information, but the innovations of artificial intelligence (AI) are now taking things further, facilitating the effective analysis and interrogation of bigdata to create new treatment hypotheses. This percentage rose to 65% amongst QA, compliance, legal and regulatory professionals.
Table of Contents Sr# Headings 1 Introduction: Why Staying Updated on Pharma News Matters 2 Emerging Trends in Pharma Marketing 3 The Role of Technology in Modern Pharma Strategies 4 Adapting to Regulatory Changes and Compliance Introduction: Why Staying Updated on Pharma News Matters In the fast-paced pharmaceutical industry, information is power.
The rise of bigdata analytics, artificial intelligence, and machine learning has revolutionized drug discovery, development, and marketing. With advancements in genomics and biotechnology, there is a move towards tailoring treatments to individual patients based on their genetic makeup.
This data-driven approach is helping companies optimize their marketing spend while maximizing impact and reach. Personalized Medicine and Targeted Campaigns Personalized medicine is revolutionizing the pharmaceutical industry by tailoring treatments to individual genetic profiles and health conditions.
We organize all of the trending information in your field so you don't have to. Join 21,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content